Details of the Drug

General Information of Drug (ID: DMB5X7Z)

Drug Name

ATG002

Indication

Disease Entry	ICD 11	Status	REF
Diabetic foot ulcer	BD54	Phase 1/2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Nicotinic acetylcholine receptor (nAChR)	TTJSZTB	NOUNIPROTAC	Agonist	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT00316537) Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers. U.S. National Institutes of Health.
2	Athenagen Advances Angiogenesis Drug to Clinical Testing. Athenagen. JUNE 21, 2006.